"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.
Ilona FridmanPeter A UbelJennifer Blumenthal-BarbyCameron V EnglandJudith S CurrierNir EyalKenneth A FreedbergScott D HalpernColleen F KelleyDaniel R KuritzkesCatherine N LeJeffrey L LennoxKathryn I PollakBrian J Zikmund-FisherKaren A ScherrPublished in: AIDS and behavior (2020)
Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options.
Keyphrases
- disease activity
- ulcerative colitis
- healthcare
- adverse drug
- rheumatoid arthritis
- systemic lupus erythematosus
- human immunodeficiency virus
- antiretroviral therapy
- hepatitis c virus
- metabolic syndrome
- type diabetes
- hiv positive
- physical activity
- computed tomography
- cross sectional
- hiv aids
- climate change
- sleep quality